ARCHIVES

Health Canada Suspends Avastin Approval; CMS Has Taken No Action After FDA Decision

This article is from The Cancer Letter archive.

Vol. 37 No. 44 | December 2, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

DRCA Board Split On Use Of Cancer Control Funds By Centers; NCAB Probably Will Decide The Issue

November 26, 1982

NIH Tells Grant Applicants One Resubmission Is Enough.

October 24, 2008

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995